Mixing claim approved for Mycoplasma vaccine from Boehringer Ingelheim

Ingelheim, Germany, 17 March 2011 – A new label claim for Boehringer Ingelheim’s pig vaccine Ingelvac MycoFLEX ^® has been approved in Europe allowing its mixing with the world leading PCV-2 vaccine Ingelvac CircoFLEX ^®. The label variation for Ingelvac MycoFLEX ^® completes a process in which Ingelvac CircoFLEX ^® had received a corresponding mixing claim by the European Commission already in July 2010.

Boehringer Ingelheim is marketing the unique flexible concept of combinable stand alone vaccines against PCV2/Mycoplasma hyopneumoniae under the name FLEXcombo ^®.
Mixing of Ingelvac CircoFLEX ^® and Ingelvac MycoFLEX ^® allows the protection of pigs against two of the most prominent and costly diseases more conveniently than in the past, using only one injection instead of up to four injections. This provides several benefits in animal welfare (less stress for pigs), farm economics (saving labour) and animal health (fewer chances for pathogen transfer via injection needles).